PMC:7321036 / 129474-130050 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T1775 139-141 SO:0001811 denotes he
T1776 173-174 SP_6;NCBITaxon:9606 denotes a
T1785 207-208 NCBITaxon:6239 denotes c
T1788 211-212 NCBITaxon:9606 denotes i
T1793 241-242 NCBITaxon:9606 denotes B
T1802 336-339 SO:0001811 denotes rti
T1804 453-455 CHEBI:32958;CHEBI:32958 denotes Ph
T1811 540-541 GO:0006468 denotes l
T1812 541-542 GO:0043234 denotes s
T1813 542-548 GO:0043234 denotes pring
T1814 555-558 GO:0043234 denotes nce
T1816 564-567 GO:0032991 denotes xes
T1817 568-569 GO:0032991 denotes P

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T212 22-25 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T213 108-111 http://purl.obolibrary.org/obo/CLO_0051582 denotes has

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T53882 91-93 Chemical denotes La http://purl.obolibrary.org/obo/CHEBI_33336

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T17 419-427 Phenotype denotes Oncology http://purl.obolibrary.org/obo/HP_0002664

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1025 0-81 Sentence denotes The Krogan laboratory has received research support from Vir Biotechnology and F.
T1026 82-100 Sentence denotes Hoffmann-La Roche.
T1027 101-203 Sentence denotes K.M.S. has consulting agreements for the following companies involving cash and/or stock compensation:
T1028 204-471 Sentence denotes Black Diamond Therapeutics, BridGene Biosciences, Denali Therapeutics, Dice Molecules, eFFECTOR Therapeutics (zotatifin and tomivosertib), Erasca, Genentech/Roche, Janssen Pharmaceuticals, Kumquat Biosciences, Kura Oncology, Merck, Mitokinin, Petra Pharma, Qulab Inc.
T1029 472-576 Sentence denotes Revolution Medicines (WDB002), Type6 Therapeutics, Venthera, and Wellspring Biosciences (Araxes Pharma).